Intravenous Zanamivir for Patients with Pneumonitis due to Pandemic (H1N1) 2009 Influenza Virus

Authors:
  • OZOliver Zimmermann
    Oliver Zimmermann
  • LMLudwig Maier
    Ludwig Maier
  • ASAxel Schubert
    Axel Schubert
  • TMThomas Mertens
    Thomas Mertens
  • PKPeter Kern
    Peter Kern
  • JWJochen Wöhrle
    Jochen Wöhrle

Abstract
We report on 2 critically ill patients with pneumonitis and acute respiratory distress syndrome due to pandemic (H1N1) 2009 influenza A virus who were treated with intravenous zanamivir and had favorable clinical outcomes. Zanamivir given intravenously may be a therapeutic option in patients with critical illness and mechanical ventilation.